PTEN and hepatocellular carcinoma: In HBV-HCC pathogenesis, upregulated miR-155 typically represses PTEN modulation of AKT/MTOR signaling in the P13K/MAPK pathway that promotes epithelial to mesenchymal transition (EMT) (68, 198).